<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Lupus on VitaminDWiki</title><link>/categories/lupus.html</link><description>Recent content in Lupus on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 04 Jan 2024 00:00:00 +0000</lastBuildDate><atom:link href="/categories/lupus/index.xml" rel="self" type="application/rss+xml"/><item><title>Lupus can progress to effect brain and nerves</title><link>/posts/lupus-can-progress-to-effect-brain-and-nerves.html</link><pubDate>Thu, 04 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/lupus-can-progress-to-effect-brain-and-nerves.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#what-is-known-about-the-effects-of-vitamin-d-in-neuropsychiatric-lupus">What is known about the effects of vitamin D in neuropsychiatric lupus?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="what-is-known-about-the-effects-of-vitamin-d-in-neuropsychiatric-lupus">What is known about the effects of vitamin D in neuropsychiatric lupus?&lt;/h4>
&lt;p>Advances in Rheumatology volume 64, Article number: 2 (2024)&lt;/p>
&lt;p>Thaís Evelyn Karnopp, Vinicius da Silva Freitas, Andressa Leite Di Domenico, Gustavo Flores Chapacais, Natália Garcia dos Santos, Eduarda Correa Freitas, Andrese Aline Gasparin &amp;amp; Odirlei André Monticielo&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/npsle.png" alt="image" width="500">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/neuro-lupus.png" alt="image" width="700">
&lt;p>Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect several organs and systems. The central and/or peripheral nervous system can suffer from complications known as neuropsychiatric lupus (NPSLE). Studies have associated the manifestations of SLE or NPSLE with vitamin D deficiency. It has been shown that hypovitaminosis D can lead to cognition deficits and cerebral hypoperfusion in patients with NPSLE. In this review article, we will address the main features related to vitamin D supplementation or serum vitamin D levels with neuropsychiatric manifestations, either in patients or in animal models of NPSLE.&lt;/p></description></item><item><title>Autoimmune diseases caused in first day after COVID Vaccination</title><link>/posts/autoimmune-diseases-caused-in-first-day-after-covid-vaccination.html</link><pubDate>Tue, 17 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/autoimmune-diseases-caused-in-first-day-after-covid-vaccination.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#covid-19-vaccines-immediate-onset-autoimmune-disease-adverse-events-in-vaers">COVID-19 vaccines immediate onset Autoimmune Disease adverse events in VAERS&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="covid-19-vaccines-immediate-onset-autoimmune-disease-adverse-events-in-vaers">COVID-19 vaccines immediate onset Autoimmune Disease adverse events in VAERS&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://darrellricke.substack.com/p/covid-19-vaccines-immediate-onset?utm_source=cross-post&amp;amp;publication_id=735472&amp;amp;post_id=138024521&amp;amp;utm_campaign=583200&amp;amp;isFreemail=false&amp;amp;r=ofo3r&amp;amp;utm_medium=email">Substack&lt;/a> Oct 16&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ae-table.jpg" alt="image" width="500"></description></item><item><title>Autoimmune RA, SLE, SSc, genes and Vitamin D</title><link>/posts/autoimmune-ra-sle-ssc-genes-and-vitamin-d.html</link><pubDate>Wed, 29 Mar 2023 00:00:00 +0000</pubDate><guid>/posts/autoimmune-ra-sle-ssc-genes-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#involvement-of-the-secosteroid-vitamin-d-in-autoimmune-rheumatic-diseases-and-covid-19">Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="involvement-of-the-secosteroid-vitamin-d-in-autoimmune-rheumatic-diseases-and-covid-19">Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19&lt;/h4>
&lt;p>nature reviews rheumatology &lt;a href="https://doi.org/10.1038/s41584-023-00944-2">https://doi.org/10.1038/s41584-023-00944-2&lt;/a>&lt;/p>
&lt;p>Maurizio Cutolo®1 S, Vanessa Smith®2, Sabrina Paolino®1 &amp;amp; Emanuele Gotelli®1 Abstract&lt;/p>
&lt;p>’Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties (DiMI), University of Genova-IRCCS San Martino Polyclinic Hospital, Genoa, Italy. 2Department of Internal Medicine, Department of Rheumatology, University Hospital Ghent, Ghent, Belgium. e-mail: &lt;a href="mailto:tolo@unige.it">tolo@unige.it&lt;/a>&lt;/p></description></item><item><title>Lupus: 60,000 IU Vitamin D monthly got to only 34 ng, not enough to help – RCT</title><link>/posts/lupus-60000-iu-vitamin-d-monthly-got-to-only-34-ng-not-enough-to-help-rct.html</link><pubDate>Wed, 04 Jan 2023 00:00:00 +0000</pubDate><guid>/posts/lupus-60000-iu-vitamin-d-monthly-got-to-only-34-ng-not-enough-to-help-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#clinical-and-serological-association-of-plasma-25-hydroxyvitamin-d-25ohd-levels-in-lupus-and-the-short-term-effects-of-oral-vitamin-d-supplementation">Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#notebetter-if-has-used-more-frequent-dosing-gut-friendly-d-or-probiotics">Note:Better if has used more frequent dosing, gut-friendly D, or probiotics&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="clinical-and-serological-association-of-plasma-25-hydroxyvitamin-d-25ohd-levels-in-lupus-and-the-short-term-effects-of-oral-vitamin-d-supplementation">Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation&lt;/h4>
&lt;p>Arthritis Res Ther . 2023 Jan 3;25(1):2. &lt;a href="https://doi.org/10.1186/s13075-022-02976-7.">doi: 10.1186/s13075-022-02976-7.&lt;/a>&lt;/p>
&lt;p>Chengappa Kavadichanda 1, Pratibha Singh 2, Supriya Maurya 2, Sneha Tota 2, Aberaame Kiroubagarin 1, Deepika Kounassegarane 1, Swathi Anand 1, Vir Singh Negi 1 3, Amita Aggarwal 4&lt;/p></description></item><item><title>Diseases treated by high-dose Vitamin D - many studies</title><link>/posts/diseases-treated-by-high-dose-vitamin-d-many-studies.html</link><pubDate>Sun, 04 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/diseases-treated-by-high-dose-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#testimonials-of-20-diseases-treated-by-coimbra-protocol">Testimonials of 20 diseases treated by Coimbra protocol&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#web---misc">Web - misc&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="testimonials-of-20-diseases-treated-by-coimbra-protocol">Testimonials of 20 diseases treated by Coimbra protocol&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.coimbraprotocol.com/testimonials-1">URL&lt;/a>   &lt;a href="/posts/beyond-vitamin-d-book-of-testimonials-on-high-dose-coimbra-protocol-aug-2021">Book - 2021&lt;/a>&lt;/strong>&lt;/p>
&lt;p>As of Oct 2022 the diseases include&lt;/p>
&lt;p>71 Multiple sclerosis&lt;/p>
&lt;p>7 Rheumatoid arthritis&lt;/p>
&lt;p>7 Atopic dermatitis&lt;/p>
&lt;p>4 Myasthenia gravis&lt;/p>
&lt;p>3 Vitiligo&lt;/p>
&lt;p>3 Psoriasis&lt;/p>
&lt;p>2 Neuromyelitis Optica (NMO) or Devic&amp;rsquo;s disease&lt;/p>
&lt;p>2 Lupus&lt;/p>
&lt;p>2 Lyme disease&lt;/p>
&lt;p>2 Sjogren&amp;rsquo;s syndrome&lt;/p>
&lt;p>1 Spongiotic dermatitis&lt;/p>
&lt;p>1 Fibromyalgia&lt;/p>
&lt;p>1 Alopecia&lt;/p>
&lt;p>1 Schleroderma&lt;/p>
&lt;p>1 Sjogren&amp;rsquo;s syndrome&lt;/p></description></item><item><title>Review of autoimmune skin diseases and Vitamin D ignores topical form</title><link>/posts/review-of-autoimmune-skin-diseases-and-vitamin-d-ignores-topical-form.html</link><pubDate>Tue, 29 Nov 2022 00:00:00 +0000</pubDate><guid>/posts/review-of-autoimmune-skin-diseases-and-vitamin-d-ignores-topical-form.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-role-of-vdvdr-signaling-pathway-in-autoimmune-skin-diseases">The role of VD/VDR signaling pathway in autoimmune skin diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-role-of-vdvdr-signaling-pathway-in-autoimmune-skin-diseases">The role of VD/VDR signaling pathway in autoimmune skin diseases&lt;/h4>
&lt;p>Mini Rev Med Chem . 2022 Nov 24. &lt;a href="https://doi.org/10.2174/1389557523666221124123206">doi: 10.2174/1389557523666221124123206&lt;/a>   PDF is behind a $95 paywall&lt;/p>
&lt;p>Yilan Zeng 1 , Shengbo Yang 1 , Dan Wang 1 , Yuanhong Liu 1 , Ziting Tang 1 , Xuemei Li 1 , Xiule Zong 1&lt;/p>
&lt;p>Background: Immune-related cutaneous diseases are a series of disorders, such as&lt;/p></description></item><item><title>Lupus associated with another poor vitamin D gene (CYP27B1 – in addition to low Vitamin D and poor VDR)</title><link>/posts/lupus-associated-with-another-poor-vitamin-d-gene-cyp27b1-in-addition-to-low-vitamin-d-and-poor-vdr.html</link><pubDate>Fri, 04 Nov 2022 00:00:00 +0000</pubDate><guid>/posts/lupus-associated-with-another-poor-vitamin-d-gene-cyp27b1-in-addition-to-low-vitamin-d-and-poor-vdr.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-synthesizing-enzyme-cyp27b1-in-systemic-lupus-erythematosus">The role of vitamin D-synthesizing enzyme CYP27B1 in systemic lupus erythematosus&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-2021-study-found-lupus-to-be-29-x-more-likely-if-a-poor-cyp24b1-gene">A 2021 study found Lupus to be 2.9 X more likely if a poor CYP24B1 gene&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lupus-having-a-poor-gi-function-probably-needs-large-doses-of-a-gut-friendly-form-of-vitamin-d">Lupus, having a poor GI function, probably needs large doses of a gut-friendly form of vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-role-of-vitamin-d-synthesizing-enzyme-cyp27b1-in-systemic-lupus-erythematosus">The role of vitamin D-synthesizing enzyme CYP27B1 in systemic lupus erythematosus&lt;/h4>
&lt;p>Turk J Med Sci. 2022 Aug;52(4):984-989. &lt;a href="https://doi.org/10.55730/1300-0144.53899">doi: 10.55730/1300-0144.53899&lt;/a>&lt;/p>
&lt;p>Man Luo 1 , Jing Lıu 2 , Yeshuang Yuan 2 , Yong Chen 3 , Guohua Yuan 2&lt;/p></description></item><item><title>Autoimmune diseases fought by Vitamin D, especially if have more than 40 ng</title><link>/posts/autoimmune-diseases-fought-by-vitamin-d-especially-if-have-more-than-40-ng.html</link><pubDate>Wed, 14 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/autoimmune-diseases-fought-by-vitamin-d-especially-if-have-more-than-40-ng.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#an-update-on-the-effects-of-vitamin-d-on-the-immune-system-and-autoimmune-diseases">An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="an-update-on-the-effects-of-vitamin-d-on-the-immune-system-and-autoimmune-diseases">An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases&lt;/h4>
&lt;p>Int J Mol Sci. 2022 Aug 29;23(17):9784 &lt;a href="https://doi.org/10.3390/ijms23179784.">doi: 10.3390/ijms23179784.&lt;/a>&lt;/p>
&lt;p>Claudia Sîrbe 1 2 , Simona Rednic 3 4 , Alina Grama 1 2 , Tudor Lucian Pop 1 2&lt;/p>
&lt;p>&lt;strong>PDF Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/toc-autoimmune.jpg" alt="image" width="500">
&lt;p>Vitamin D intervenes in calcium and phosphate metabolism and bone homeostasis. Experimental studies have shown that 1,25-dihydroxyvitamin D (calcitriol) generates immunologic activities on the innate and adaptive immune system and endothelial membrane stability. Low levels of serum 25-hydroxyvitamin D (25(OH)D) are associated with an increased risk of developing immune-related diseases such as psoriasis, type 1 diabetes, multiple sclerosis, and autoimmune diseases. Various clinical trials describe the efficacy of supplementation of vitamin D and its metabolites for treating these diseases that result in variable outcomes. Different disease outcomes are observed in treatment with vitamin D as high inter-individual difference is present with complex gene expression in human peripheral blood mononuclear cells. However, it is still not fully known what level of serum 25(OH)D is needed. The current recommendation is to increase vitamin D intake and have enough sunlight exposure to have serum 25(OH)D at a level of 30 ng/mL (75 nmol/L) and &lt;strong>better at 40-60 ng/mL (100-150 nmol/L) to obtain the optimal health benefits of vitamin D.&lt;/strong>&lt;/p></description></item><item><title>Lupus not helped by an unknown amount of Vitamin D</title><link>/posts/lupus-not-helped-by-an-unknown-amount-of-vitamin-d.html</link><pubDate>Wed, 29 Jun 2022 00:00:00 +0000</pubDate><guid>/posts/lupus-not-helped-by-an-unknown-amount-of-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#real-world-data-on-vitamin-d-supplementation-and-its-impacts-in-systemic-lupus-erythematosus-cross-sectional-analysis-of-a-lupus-registry-of-nationwide-institutions-luna">Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="real-world-data-on-vitamin-d-supplementation-and-its-impacts-in-systemic-lupus-erythematosus-cross-sectional-analysis-of-a-lupus-registry-of-nationwide-institutions-luna">Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA)&lt;/h4>
&lt;p>PLoS One. 2022 Jun 29;17(6):e0270569. &lt;a href="https://doi.org/10.1371/journal.pone.0270569">doi: 10.1371/journal.pone.0270569&lt;/a>&lt;/p>
&lt;p>Keigo Hayashi 1, Ken-Ei Sada 1 2, Yosuke Asano 1, Yu Katayama 1, Keiji Ohashi 1, Michiko Morishita 1, Yoshia Miyawaki 1, Haruki Watanabe 1, Takayuki Katsuyama 1, Mariko Narazaki 1, Yoshinori Matsumoto 1, Nobuyuki Yajima 3 4, Ryusuke Yoshimi 5, Yasuhiro Shimojima 6, Shigeru Ohno 7, Hiroshi Kajiyama 8, Kunihiro Ichinose 9, Shuzo Sato 10, Michio Fujiwara 11, Jun Wada 1&lt;/p></description></item><item><title>Vitamin D is a biomarker for autoimmune, neurological and psychiatric diseases</title><link>/posts/vitamin-d-is-a-biomarker-for-autoimmune-neurological-and-psychiatric-diseases.html</link><pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-a-biomarker-for-autoimmune-neurological-and-psychiatric-diseases.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#serum-vitamin-d-as-a-biomarker-in-autoimmune-psychiatric-and-neurodegenerative-diseases">Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="serum-vitamin-d-as-a-biomarker-in-autoimmune-psychiatric-and-neurodegenerative-diseases">Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases&lt;/h4>
&lt;p>Diagnostics 2022, 12, 130. https:// doi.org/ 10.3390/diagnostics12010130&lt;/p>
&lt;p>&lt;strong>Autoimmune&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/auto1.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/auto2.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/auto3.jpg" alt="image" width="900">
&lt;p>&lt;strong>Depression Schizophrenia&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mdd1.jpg" alt="image" width="800">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mdd2.jpg" alt="image" width="800">
&lt;p>Giulia Bivona , Caterina Maria Gambino 1,+, Bruna Lo Sasso 1, Concetta Scazzone 1, Rosaria Vincenza Giglio 1, Luisa Agnello 1 and Marcello Ciaccio 1,2/*&lt;/p>
&lt;p>Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, University of Palermo, 90127 Palermo, Italy; &lt;a href="mailto:giulia.bivona@unipa.it">giulia.bivona@unipa.it&lt;/a> (G.B.); &lt;a href="mailto:cmgambino@libero.it">cmgambino@libero.it&lt;/a> (C.M.G.); &lt;a href="mailto:bruna.losasso@unipa.it">bruna.losasso@unipa.it&lt;/a> (B.L.S.); &lt;a href="mailto:concetta.scazzone@unipa.it">concetta.scazzone@unipa.it&lt;/a> (C.S.); &lt;a href="mailto:giglio.rosaria.vincenza@gmail.com">giglio.rosaria.vincenza@gmail.com&lt;/a> (R.V.G.); &lt;a href="mailto:luisa.agnello@unipa.it">luisa.agnello@unipa.it&lt;/a> (L.A.)&lt;/p></description></item><item><title>Every aspect of Lupus is associated with low viramin D</title><link>/posts/every-aspect-of-lupus-is-associated-with-low-viramin-d.html</link><pubDate>Sat, 16 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/every-aspect-of-lupus-is-associated-with-low-viramin-d.html</guid><description/></item><item><title>Rheumatic Diseases often treated by Vitamin D, may need 40-60 ng</title><link>/posts/rheumatic-diseases-often-treated-by-vitamin-d-may-need-40-60-ng.html</link><pubDate>Fri, 01 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/rheumatic-diseases-often-treated-by-vitamin-d-may-need-40-60-ng.html</guid><description>&lt;h4 id="vitamin-d-and-rheumatic-diseases-a-review-of-clinical-evidence">Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2021, 22, 10659. &lt;a href="https://doi.org/10.3390/ijms221910659">https://doi.org/10.3390/ijms221910659&lt;/a>&lt;/p>
&lt;p>Nipith Charoenngam 1,2,3&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Dept of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA 02138, USA;&lt;br>
 ~  &lt;a href="mailto:nipith.charoenngam@gmail.com">nipith.charoenngam@gmail.com&lt;/a>   or perhaps &lt;a href="mailto:ncharoen@bu.edu">ncharoen@bu.edu&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Section Endocrinology, Diabetes, Nutrition and Weight Management, Dept of Medicine, Boston University School of Medicine, Boston, MA 02118, USA&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Medicine, Faculty of Medicine SirirajHospital, Mahidol University, Bangkok 10700, Thailand&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>Vitamin D plays an important role in maintaining a healthy mineralized skeleton. It is also considered an immunomodulatory agent that regulates innate and adaptive immune systems. The aim of this narrative review is to provide general concepts of vitamin D for the skeletal and immune health, and to summarize the mechanistic, epidemiological, and clinical evidence on the relationship between vitamin D and rheumatic diseases.&lt;/p></description></item><item><title>Vitamin D Resistance hypothesis confirmed by Coimbra high-dose vitamin D protocol</title><link>/posts/vitamin-d-resistance-hypothesis-confirmed-by-coimbra-high-dose-vitamin-d-protocol.html</link><pubDate>Wed, 07 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-resistance-hypothesis-confirmed-by-coimbra-high-dose-vitamin-d-protocol.html</guid><description>&lt;p>&lt;strong>Vitamin D resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by a Therapeutic High-Dose Vitamin D Protocol&lt;/strong>&lt;/p>
&lt;p>Frontiers in Immunology – Hypothesis and Theory &lt;a href="https://doi.org/10.3389/fimmu.2021.655739">doi: 10.3389/fimmu.2021.655739&lt;/a>&lt;/p>
&lt;p>Dirk Lemke1&amp;rsquo; Rainer Johannes Klement2 &lt;a href="mailto:rainer_klement@gmx.de">rainer_klement@gmx.de&lt;/a>，Felix Schweiger3, Beatrix Schweiger3 and Jorg Spitz4&lt;/p>
&lt;p>1 Praxis Dr. Beatrix Schweiger, Bensheim, Germany, 2 Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany, 3 Praxis Dr. Beatrix Schweiger, Waldkirch, Germany, 4Akademie fur menschliche Medizin und evolutionare Gesundheit, Schlangenbad, Germany&lt;/p></description></item><item><title>Lupus 3.8 X more likely if a poor Vitamin D Receptor</title><link>/posts/lupus-38-x-more-likely-if-a-poor-vitamin-d-receptor.html</link><pubDate>Mon, 20 May 2019 00:00:00 +0000</pubDate><guid>/posts/lupus-38-x-more-likely-if-a-poor-vitamin-d-receptor.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-receptor-expression-in-peripheral-blood-mononuclear-cells-is-inversely-associated-with-disease-activity-and-inflammation-in-lupus-patients">Vitamin D receptor expression in peripheral blood mononuclear cells is inversely associated with disease activity and inflammation in lupus patients.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#13-studies-cited-this-study-as-of-june-2023">13 studies cited this study as of June 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#10300-hits-when-search-google-scholar--for-lupus-vitamin-d-receptor">10,300+ hits when search Google Scholar for lupus &amp;ldquo;vitamin D Receptor&amp;rdquo;&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-receptor-expression-in-peripheral-blood-mononuclear-cells-is-inversely-associated-with-disease-activity-and-inflammation-in-lupus-patients">Vitamin D receptor expression in peripheral blood mononuclear cells is inversely associated with disease activity and inflammation in lupus patients.&lt;/h4>
&lt;p>Clin Rheumatol. 2019 May 18. &lt;a href="https://doi.org/10.1007/s10067-019-04594-2.">doi: 10.1007/s10067-019-04594-2.&lt;/a>&lt;/p>
&lt;p>Sun J1, Liu C2, Zhang S1, Yi B1, Gui M1, Zhang W1, Li YC3, Zhang H4.&lt;/p></description></item><item><title>Resveratrol Role in Autoimmune Disease-A Mini-Review.</title><link>/posts/resveratrol-role-in-autoimmune-disease-a-mini-review.html</link><pubDate>Sat, 27 Apr 2019 00:00:00 +0000</pubDate><guid>/posts/resveratrol-role-in-autoimmune-disease-a-mini-review.html</guid><description>&lt;h4 id="24papers-cited-this-study-as-of-dec-2019httpsscholargooglecomscholarstart10hlenas_sdt2005sciodt05cites16007764044149251022scipsc">&lt;a href="https://scholar.google.com/scholar?start=10&amp;amp;hl=en&amp;amp;as_sdt=2005&amp;amp;sciodt=0,5&amp;amp;cites=16007764044149251022&amp;amp;scipsc=">24papers cited this study as of Dec 2019&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Polyphenols in the treatment of autoimmune diseases = July 2019 10.1016/j.autrev.2019.05.001&lt;/p>
&lt;ul>
&lt;li>various autoimmune disorders including vitiligo, ulcerative colitis and multiple sclerosis (MS)&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1- 2018 - &lt;a href="https://doi.org/10.1155/2018/8152373">https://doi.org/10.1155/2018/8152373&lt;/a> FREE PDF&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy - Jan 2019 - &lt;a href="https://doi.org/10.3389/fphar.2018.01534">doi: 10.3389/fphar.2018.01534&lt;/a> FREE PDF&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h4 id="searched-resveratrol-and-autoimmune-in-pubmed-as-of-dec-2019">Searched Resveratrol and Autoimmune in PubMed as of Dec 2019&lt;/h4>
&lt;ul>
&lt;li>Influence of Resveratrol on the Immune Response - April 2019 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/influence-of-resveratrol-on-the-immune-response.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/resveratrol-role-in-autoimmune.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Immunological effects of vitamin D and their relations to autoimmunity</title><link>/posts/immunological-effects-of-vitamin-d-and-their-relations-to-autoimmunity.html</link><pubDate>Tue, 19 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/immunological-effects-of-vitamin-d-and-their-relations-to-autoimmunity.html</guid><description>&lt;p>J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30033-2. &lt;a href="https://doi.org/10.1016/j.jaut.2019.03.002.">doi: 10.1016/j.jaut.2019.03.002.&lt;/a>&lt;/p>
&lt;p>Yamamoto E1, Jørgensen TN2.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/autoimmunity-sci-hub.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Animal Model of Autoimmunity&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/autoimmunity-animal.jpg" alt="image" width="900">
&lt;p>Vitamin D deficiency is an established risk factor for many autoimmune diseases and the anti-inflammatory properties of vitamin D underscore its potential therapeutic value for these diseases. However, results of vitamin D3 supplementation clinical trials have been varied. To understand the clinical heterogeneity, we reviewed the pre-clinical data on vitamin D activity in four common autoimmune diseases:&lt;/p></description></item><item><title>How Vitamin D reduces inflammation, improves immunity and fights autoimmunity – review</title><link>/posts/how-vitamin-d-reduces-inflammation-improves-immunity-and-fights-autoimmunity-review.html</link><pubDate>Sun, 17 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-reduces-inflammation-improves-immunity-and-fights-autoimmunity-review.html</guid><description/></item><item><title>Lupus patients are 5 X more likely to have low vitamin D – many meta-analyses</title><link>/posts/lupus-patients-are-5-x-more-likely-to-have-low-vitamin-d-many-meta-analyses.html</link><pubDate>Tue, 15 Jan 2019 00:00:00 +0000</pubDate><guid>/posts/lupus-patients-are-5-x-more-likely-to-have-low-vitamin-d-many-meta-analyses.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#lupus-66-x-nore-if-low-vitamin-d---meta-analysis---jan-2019">Lupus 6.6 X nore if low vitamin D - meta-analysis - Jan 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lupus-44-x-nore-if-low-vitamin-d---meta-analysis-aug-2019">Lupus 4.4 X nore if low vitamin D - meta-analysis Aug 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lupus-meta-analysis---sept-2019">Lupus meta-analysis - Sept 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lupus-meta-analysis---june-2022">Lupus Meta-analysis - June 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="lupus-66-x-nore-if-low-vitamin-d---meta-analysis---jan-2019">Lupus 6.6 X nore if low vitamin D - meta-analysis - Jan 2019&lt;/h4>
&lt;p>&lt;strong>Decreased serum/plasma vitamin D levels in SLE patients: A Meta-analysis.&lt;/strong>&lt;/p>
&lt;p>Curr Pharm Des. 2019 Jan 11. &lt;a href="https://doi.org/10.2174/1381612825666190111145848">doi: 10.2174/1381612825666190111145848&lt;/a>&lt;/p>
&lt;p>Wang XR1, Xiao JP2, Zhang JJ3, Wu YG1.&lt;/p></description></item><item><title>Impact of Vitamin D on Lupus</title><link>/posts/impact-of-vitamin-d-on-lupus.html</link><pubDate>Fri, 10 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/impact-of-vitamin-d-on-lupus.html</guid><description/></item><item><title>Lupus associated with low vitamin D – Caucasian 2.2 X, Arab 4.6 X – meta-analysis</title><link>/posts/lupus-associated-with-low-vitamin-d-caucasian-22-x-arab-46-x-meta-analysis.html</link><pubDate>Thu, 08 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/lupus-associated-with-low-vitamin-d-caucasian-22-x-arab-46-x-meta-analysis.html</guid><description/></item><item><title>Juvenile Lupus treated by Vitamin D – need more studies to understand why</title><link>/posts/juvenile-lupus-treated-by-vitamin-d-need-more-studies-to-understand-why.html</link><pubDate>Mon, 22 Jan 2018 00:00:00 +0000</pubDate><guid>/posts/juvenile-lupus-treated-by-vitamin-d-need-more-studies-to-understand-why.html</guid><description/></item><item><title>Lupus is both prevented and treated by Vitamin D – review</title><link>/posts/lupus-is-both-prevented-and-treated-by-vitamin-d-review.html</link><pubDate>Tue, 26 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/lupus-is-both-prevented-and-treated-by-vitamin-d-review.html</guid><description/></item><item><title>Lupus reduced when half of participants got to 38 ng of Vitamin D (not statistically significant) – RCT</title><link>/posts/lupus-reduced-when-half-of-participants-got-to-38-ng-of-vitamin-d-not-statistically-significant-rct.html</link><pubDate>Tue, 26 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/lupus-reduced-when-half-of-participants-got-to-38-ng-of-vitamin-d-not-statistically-significant-rct.html</guid><description>&lt;h4 id="the-effect-of-vitamin-d-supplementation-in-disease-activity-of-systemic-lupus-erythematosus-patients-with-vitamin-d-deficiency-a-randomized-clinical-trial">The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: A randomized clinical trial.&lt;/h4>
&lt;p>J Res Med Sci. 2017 Jan 27;22:4. &lt;a href="https://doi.org/10.4103/1735-1995.199089.">doi: 10.4103/1735-1995.199089.&lt;/a> eCollection 2017.&lt;/p>
&lt;p>Karimzadeh H1, Shirzadi M1, Karimifar M1.&lt;/p>
&lt;p>Department of Rheumatology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>50,000 weekly for 12 weeks, then 50,000 IU monthly for 3 months&lt;/p>
&lt;p>They did not use a high enough dose of Vitamin D&lt;/p></description></item><item><title>Inflammation and immune responses to Vitamin D (perhaps need to measure active vitamin D)</title><link>/posts/inflammation-and-immune-responses-to-vitamin-d-perhaps-need-to-measure-active-vitamin-d.html</link><pubDate>Wed, 22 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/inflammation-and-immune-responses-to-vitamin-d-perhaps-need-to-measure-active-vitamin-d.html</guid><description>&lt;p>&lt;strong>Summary table on effects of calcitriol on immune and inflammatory cells&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/inflammatory-t1.jpg" alt="image">
&lt;h4 id="concluding-remarks---clipped-from-pdf">Concluding remarks - clipped from PDF&lt;/h4>
&lt;p>There is a growing body of evidence that VitD, especially its active metabolite, plays a key role in modulating the physiological activity of the immune system. This emergent role has stimulated a florid line of research aimed at associating the level of VitD with pathological situations wherein the immune system may be altered, such as in autoimmunity and inflammation.&lt;/p></description></item><item><title>Autoimmune diseases associated with low Vitamin D and Vitamin D Receptor</title><link>/posts/autoimmune-diseases-associated-with-low-vitamin-d-and-vitamin-d-receptor.html</link><pubDate>Sun, 12 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/autoimmune-diseases-associated-with-low-vitamin-d-and-vitamin-d-receptor.html</guid><description/></item><item><title>Lupus fought by Vitamin D in all trials longer than 12 weeks - review</title><link>/posts/lupus-fought-by-vitamin-d-in-all-trials-longer-than-12-weeks-review.html</link><pubDate>Tue, 24 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/lupus-fought-by-vitamin-d-in-all-trials-longer-than-12-weeks-review.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effect-of-vitamin-d-supplementation-on-patients-with-systemic-lupus-erythematosus-a-systematic-review">Effect of vitamin D supplementation on patients with systemic lupus erythematosus: a systematic review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effect-of-vitamin-d-supplementation-on-patients-with-systemic-lupus-erythematosus-a-systematic-review">Effect of vitamin D supplementation on patients with systemic lupus erythematosus: a systematic review&lt;/h4>
&lt;p>Revista Brasileira de Reumatologia (English Edition), Vol 57 #5, Sept–Oct 2017, Pages 466–471, &lt;a href="https://doi.org/10.1016/j.rbre.2017.08.001">https://doi.org/10.1016/j.rbre.2017.08.001&lt;/a>&lt;/p>
&lt;p>Joyce Ramalho Sousaa, Érica Patrícia Cunha Rosaa, Ivone Freires de Oliveira Costa Nunesb, , , Cecilia Maria Resende Gonçalves de Carvalhob&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>Only rarely will a 12 week or shorter trial be successful. Even when enough vitamin D is given. It typically takes 8-12 weeks to get vitamin D levels up high enough to be of any benefit.&lt;/strong>&lt;/p></description></item><item><title>Dermatologists are reminded of the importance of vitamin D in 8 diseases</title><link>/posts/dermatologists-are-reminded-of-the-importance-of-vitamin-d-in-8-diseases.html</link><pubDate>Wed, 11 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/dermatologists-are-reminded-of-the-importance-of-vitamin-d-in-8-diseases.html</guid><description/></item><item><title>Omega-3 reduces Lupus, Rheumatoid Arthritis and Osteoarthritis – review</title><link>/posts/omega-3-reduces-lupus-rheumatoid-arthritis-and-osteoarthritis-review.html</link><pubDate>Sun, 20 Aug 2017 00:00:00 +0000</pubDate><guid>/posts/omega-3-reduces-lupus-rheumatoid-arthritis-and-osteoarthritis-review.html</guid><description/></item><item><title>Lupus in children 2.6 X more likely if they had poor Vitamin D Receptor</title><link>/posts/lupus-in-children-26-x-more-likely-if-they-had-poor-vitamin-d-receptor.html</link><pubDate>Sat, 12 Aug 2017 00:00:00 +0000</pubDate><guid>/posts/lupus-in-children-26-x-more-likely-if-they-had-poor-vitamin-d-receptor.html</guid><description/></item><item><title>It is time to routinely give vitamin D to Lupus patients</title><link>/posts/it-is-time-to-routinely-give-vitamin-d-to-lupus-patients.html</link><pubDate>Tue, 10 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/it-is-time-to-routinely-give-vitamin-d-to-lupus-patients.html</guid><description/></item><item><title>Connective tissue disorders (Lupus, RA, etc) treated by vitamin D</title><link>/posts/connective-tissue-disorders-lupus-ra-etc-treated-by-vitamin-d.html</link><pubDate>Sun, 08 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/connective-tissue-disorders-lupus-ra-etc-treated-by-vitamin-d.html</guid><description/></item><item><title>Lupus associated with both low vitamin D and Vitamin D receptor problems</title><link>/posts/lupus-associated-with-both-low-vitamin-d-and-vitamin-d-receptor-problems.html</link><pubDate>Mon, 17 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/lupus-associated-with-both-low-vitamin-d-and-vitamin-d-receptor-problems.html</guid><description/></item><item><title>If Lupus in family – 5 times more likely to get Lupus if low vitamin D and poor CYP24A1</title><link>/posts/if-lupus-in-family-5-times-more-likely-to-get-lupus-if-low-vitamin-d-and-poor-cyp24a1.html</link><pubDate>Sat, 11 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/if-lupus-in-family-5-times-more-likely-to-get-lupus-if-low-vitamin-d-and-poor-cyp24a1.html</guid><description>&lt;h4 id="combined-role-of-vitamin-d-status-and-cyp24a1-in-the-transition-to-systemic-lupus-erythematosus">Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.&lt;/h4>
&lt;p>Ann Rheum Dis. 2016 Jun 9. pii: annrheumdis-2016-209157. &lt;a href="https://doi.org/10.1136/annrheumdis-2016-209157.">doi: 10.1136/annrheumdis-2016-209157.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Young KA1, Munroe ME2, Guthridge JM2, Kamen DL3, Niewold TB4, Gilkeson GS3, Weisman MH5, Ishimori ML5, Kelly J2, Gaffney PM2, Sivils KH2, Lu R6, Wallace DJ5, Karp DR7, Harley JB8, James JA6, Norris JM1.&lt;/p>
&lt;p>1Colorado School of Public Health, Aurora, Colorado, USA.&lt;/p></description></item><item><title>Lupus – vitamin D is essential in preventing and modulating it</title><link>/posts/lupus-vitamin-d-is-essential-in-preventing-and-modulating-it.html</link><pubDate>Fri, 08 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/lupus-vitamin-d-is-essential-in-preventing-and-modulating-it.html</guid><description>&lt;h3 id="eppur-si-muove">Eppur Si Muove:&lt;/h3>
&lt;p>vitamin D is essential in preventing and modulating SLE&lt;/p>
&lt;p>Lupus May 2016 vol. 25 no. 6 563-572&lt;/p>
&lt;p>S Azrielant1, Y Shoenfeld1,2⇑&lt;/p>
&lt;p>1The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel&lt;/p>
&lt;p>2Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Israel&lt;/p>
&lt;p>Yehuda Shoenfeld, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 5265601, Israel. Email: &lt;a href="mailto:shoenfel@post.tau.ac.il">shoenfel@post.tau.ac.il&lt;/a>&lt;/p></description></item><item><title>2,000 IU vitamin D recommended for pediatric rheumatology</title><link>/posts/2000-iu-vitamin-d-recommended-for-pediatric-rheumatology.html</link><pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/2000-iu-vitamin-d-recommended-for-pediatric-rheumatology.html</guid><description/></item><item><title>Juvenile Lupus fatigue reduced by vitamin D ( 50,000 IU weekly for 6 months) – RCT</title><link>/posts/juvenile-lupus-fatigue-reduced-by-vitamin-d-50000-iu-weekly-for-6-months-rct.html</link><pubDate>Mon, 18 May 2015 00:00:00 +0000</pubDate><guid>/posts/juvenile-lupus-fatigue-reduced-by-vitamin-d-50000-iu-weekly-for-6-months-rct.html</guid><description>&lt;h4 id="a-randomized-double-blind-placebo-controlled-trial-of-vitamin-d-supplementation-in-adolescents-and-young-adults-with-juvenile-onset-sle-improvement-in-disease-activity-and-fatigue-scores">A randomized double-blind placebo-controlled trial of vitamin D supplementation in adolescents and young adults with Juvenile-onset SLE: Improvement in disease activity and fatigue scores&lt;/h4>
&lt;p>Arthritis Care and Research, DOI: 10.1002/acr.22621&lt;/p>
&lt;p>Glauce L Lima1, Juliane Paupitz1, Nadia E Aikawa1,2, Liliam Takayama1, Eloisa Bonfa1 andRosa M. R. Pereira1,*&lt;/p>
&lt;p>1Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, Brazil&lt;/p>
&lt;p>2Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo, Brazil&lt;/p></description></item><item><title>Lupus is associated with low vitamin D (research in Southern Hemisphere concurs)</title><link>/posts/lupus-is-associated-with-low-vitamin-d-research-in-southern-hemisphere-concurs.html</link><pubDate>Sun, 19 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/lupus-is-associated-with-low-vitamin-d-research-in-southern-hemisphere-concurs.html</guid><description>&lt;h3 id="vitamin-d-tracks-systemic-lupus-erythematosus-activityhttpwwwmedpagetodaycomrheumatologylupus5103020-medpagetoday">&lt;a href="http://www.medpagetoday.com/Rheumatology/Lupus/51030%20">Vitamin D Tracks Systemic Lupus Erythematosus Activity&lt;/a> MedPageToday&lt;/h3>
&lt;p>&lt;strong>“Study first in Southern Hemisphere to examine role of vitamin D in SLE disease activity”&lt;/strong>&lt;/p></description></item><item><title>Lupus not treated by monthly 50,000 IU vitamin D (no surprise) – RCT</title><link>/posts/lupus-not-treated-by-monthly-50000-iu-vitamin-d-no-surprise-rct.html</link><pubDate>Mon, 23 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/lupus-not-treated-by-monthly-50000-iu-vitamin-d-no-surprise-rct.html</guid><description/></item><item><title>Musculoskeletal pain reduced with 4,000 IU of vitamin D – RCT</title><link>/posts/musculoskeletal-pain-reduced-with-4000-iu-of-vitamin-d-rct.html</link><pubDate>Mon, 23 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/musculoskeletal-pain-reduced-with-4000-iu-of-vitamin-d-rct.html</guid><description>&lt;h4 id="a-randomized-double-blind-placebo-controlled-study-adding-high-dose-vitamin-d-to-analgesic-regimens-in-patients-with-musculoskeletal-pain">A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain&lt;/h4>
&lt;p>Lupus April 2015 vol. 24 no. 4-5 483-489, &lt;a href="https://doi.org/10.1177/0961203314558676">doi: 10.1177/0961203314558676&lt;/a>&lt;/p>
&lt;p>O Gendelman 1,2,&lt;em>; D Itzhaki 2,3,&lt;/em>; S Makarov 2,4; M Bennun 2,4; H Amital 1,2⇑&lt;/p>
&lt;p>1Department of Medicine ‘B&amp;rsquo;, Sheba Medical Center, Tel Hashomer&lt;/p>
&lt;p>2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel&lt;/p>
&lt;p>3Central Laboratory of Clalit Health Services, Tel-Aviv, Israel&lt;/p>
&lt;p>4Department of Anesthesiology, Meir Medical Center, Kfar Saba, Israel&lt;/p></description></item><item><title>Lupus is yet again strongly associated with low vitamin D (when will supplementation be tried)</title><link>/posts/lupus-is-yet-again-strongly-associated-with-low-vitamin-d-when-will-supplementation-be-tried.html</link><pubDate>Thu, 18 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/lupus-is-yet-again-strongly-associated-with-low-vitamin-d-when-will-supplementation-be-tried.html</guid><description>&lt;h3 id="association-of-hypovitaminosis-d-with-systemic-lupus-erythematosus-and-inflammation">Association of hypovitaminosis D with Systemic Lupus Erythematosus and inflammation.&lt;/h3>
&lt;p>&lt;span>[Article in English, Portuguese]&lt;/span>&lt;/p>
&lt;p>J Bras Nefrol. 2014 Dec;36(4):430-436.&lt;/p>
&lt;p>Souza VA1, Bastos MG1, Fernandes NM1, Mansur HN2, Raposo NR1, Souza DM3, Andrade LC1.&lt;/p>
&lt;p>1Universidade Federal de Juiz de Fora.&lt;/p>
&lt;p>2Universidade Salgado de Oliveira.&lt;/p>
&lt;p>3Fundação Hospitalar do Estado de Minas Gerais.&lt;/p>
&lt;p>Introduction: Nowadays it is described a high prevalence of hypovitaminosis D in Systemic Lupus Erythematosus (SLE), which is associated with some clinical manifestations and increased inflammatory activity.&lt;/p></description></item><item><title>The Antibiotic Effects of Vitamin D – 2014</title><link>/posts/the-antibiotic-effects-of-vitamin-d-2014.html</link><pubDate>Mon, 24 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/the-antibiotic-effects-of-vitamin-d-2014.html</guid><description>&lt;p>Endocrine, Metabolic &amp;amp; Immune Disorders-Drug Targets Vol 14, issue 4, Pages 255-266 (12)&lt;/p>
&lt;p>Chunxiao Guo and Adrian F. Gombart&lt;/p>
&lt;p>Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, 307 Linus Pauling Science Center, Corvallis, OR 97331, USA.&lt;/p>
&lt;p>The recent discovery that vitamin D regulates expression of the cathelicidin antimicrobial peptide gene has generated renewed interest in using vitamin D to fight infectious diseases. This review describes the historical use of vitamin D or its sources to treat infections, the mechanism of action through which vitamin D mediates its “antibiotic” effects, findings from epidemiological studies associating vitamin D deficiency with increased susceptibility to infection and clinical trials with vitamin D supplementation to treat or prevent infections. Furthermore studies examining an association between vitamin D levels and cathelicidin expression are discussed. The role of cathelcidin throughout the course of infection from the initial encounter of the pathogen to the resolution of tissue damage and inflammation indicates that individuals need to maintain adequate levels of vitamin D for an optimal immune response. In addition, for treating infections, carefully designed randomized, clinical trials that are appropriately powered to detect modest effects, target populations that are severely deficient in vitamin D, and optimized dose, dosing frequency and safety are needed.&lt;/p></description></item><item><title>Lupus reduced with vitamin D intervention</title><link>/posts/lupus-reduced-with-vitamin-d-intervention.html</link><pubDate>Sat, 08 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/lupus-reduced-with-vitamin-d-intervention.html</guid><description>&lt;h4 id="vitamin-d-and-cutaneous-lupus-erythematosus-effect-of-vitamin-d-replacement-on-disease-severity">Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity&lt;/h4>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>CLE =cutaneous lupus erythematosus = 3.5 X more chance of Vitamin D deficiency&lt;/p>
&lt;p>Cutaneous Lupus Erythematosus Disease Area and Severity Index&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Before: 0.9&lt;/p>
&lt;/li>
&lt;li>
&lt;p>After 1 year: 2.7&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>Oral vitamin D3 was recommended to cases who attended our clinic in June and July 2008, and who did not present optimal levels of 25(OH)D at or above 30 ng/ml.&lt;/p></description></item><item><title>Vitamin D2 did not help Lupus (no surprise, D2 was given weekly)</title><link>/posts/vitamin-d2-did-not-help-lupus-no-surprise-d2-was-given-weekly.html</link><pubDate>Fri, 31 May 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d2-did-not-help-lupus-no-surprise-d2-was-given-weekly.html</guid><description>&lt;h3 id="vitamin-d-in-sle-modest-association-with-disease-activity-and-urine-proteincreatinine-ratio">Vitamin D in SLE: Modest association with disease activity and urine protein/creatinine ratio&lt;/h3>
&lt;p>Arthritis &amp;amp; Rheumatism Vol. 65 Issue 6&lt;/p>
&lt;p>Michelle Petri 1,†,*, Kayode J. Bello 1, Hong Fang 1, Laurence S. Magder 2&lt;/p>
&lt;p>Objective: We investigated whether an increase in vitamin D levels in patients with systemic lupus erythematosus was associated with improvement in disease activity.&lt;/p>
&lt;p>Methods: 1006 SLE patients were followed over 128 weeks. SLE patients with low levels of 25-hydroxy Vitamin D (&amp;lt;40 ng/mL) were supplemented with 50,000 units Vitamin D2 weekly, with Ca/D3 200 units twice daily. Longitudinal regression models were used to estimate the association between levels of vitamin D and various measures of disease activity.&lt;/p></description></item><item><title>Lupus in blacks associated with low vitamin D AND short telomeres</title><link>/posts/lupus-in-blacks-associated-with-low-vitamin-d-and-short-telomeres.html</link><pubDate>Sat, 25 May 2013 00:00:00 +0000</pubDate><guid>/posts/lupus-in-blacks-associated-with-low-vitamin-d-and-short-telomeres.html</guid><description>&lt;h3 id="systemic-lupus-erythematosus-and-vitamin-d-deficiency-are-associated-with-shorter-telomere-length-among-african-americans-a-case-control-study">Systemic Lupus Erythematosus and Vitamin D Deficiency Are Associated with Shorter Telomere Length among African Americans: A Case-Control Study.&lt;/h3>
&lt;p>PLoS One. 2013 May 20;8(5):e63725. &lt;a href="https://doi.org/10.1371/journal.pone.0063725.">doi: 10.1371/journal.pone.0063725.&lt;/a> Print 2013.&lt;/p>
&lt;p>Hoffecker BM, Raffield LM, Kamen DL, Nowling TK.&lt;/p>
&lt;p>Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.&lt;/p>
&lt;p>Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that disproportionately affects African American females. The causes of SLE are unknown but postulated to be a combination of genetic predisposition and environmental triggers. Vitamin D deficiency is one of the possible environmental triggers. In this study we evaluated relationships between vitamin D status, cellular aging (telomere length) and anti-telomere antibodies among African American Gullah women with SLE. The study population included African American female SLE patients and unaffected controls from the Sea Island region of South Carolina. Serum 25-hydroxyvitamin D levels were measured using a nonchromatographic radioimmunoassay. Telomere length was measured in genomic DNA of peripheral blood mononuclear cells (PBMCs) by monochrome multiplex quantitative PCR. Anti-telomere antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Patients with SLE had significantly shorter telomeres and higher anti-telomere antibody titers compared to age- and gender-matched unaffected controls. There was a positive correlation between anti-telomere antibody levels and disease activity among patients and a significant correlation of shorter telomeres with lower 25-hydroxyvitamin D levels in both patients and controls. In follow-up examination of a subset of the patients, the patients who remained vitamin D deficient tended to have shorter telomeres than those patients whose 25-hydroxyvitamin D levels were repleted. Increasing 25-hydroxyvitamin D levels in African American patients with SLE may be beneficial in maintaining telomere length and preventing cellular aging. Moreover, anti-telomere antibody levels may be a promising biomarker of SLE status and disease activity.&lt;/p></description></item><item><title>Lupus biomarker ( regulatory T cell, treg) is associated with level of vitamin D</title><link>/posts/lupus-biomarker-regulatory-t-cell-treg-is-associated-with-level-of-vitamin-d.html</link><pubDate>Sun, 21 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/lupus-biomarker-regulatory-t-cell-treg-is-associated-with-level-of-vitamin-d.html</guid><description>&lt;h3 id="association-between-the-low-levels-of-vitamin-d-and-treg-function-in-systemic-lupus-erythematosus-patients">Association between the low levels of vitamin d and treg function in systemic lupus erythematosus patients.&lt;/h3>
&lt;p>Acta Med Indones. 2013 Jan;45(1):26-31.&lt;/p>
&lt;p>Handono K, Marisa D, Kalim H.&lt;/p>
&lt;p>Department of Clinical Pathology, Faculty of Medicine, Brawijaya University. Jl. Veteran Malang, Malang, Indonesia.&lt;/p>
&lt;p>Aim: to determine the relationships between vitamin D and CCR4 expression on Treg, and Treg migratory capacity in SLE patients in Indonesia.&lt;/p>
&lt;p>Methods: vitamin D level assesment, CCR4 expression on Treg and Treg migratory capacity were performed on 41 SLE patients and 20 healthy controls. Serum vitamin D levels were measured by ELISA (Cusabio). The expression of CCR4 on Treg was detected by flow cytometry and Treg migratory capacity was performed in chemotaxis chamber using CCR4 ligands, TARC and MDC, and subsequently analyzed by flow cytometry using FACS Calibur (Becton Dickinson). The number of migrated Treg is the ratio of CD4+CD25+CCR4+ cells number in lower chamber of chemotaxis compared to the total number of CD4+CD25+CCR4+ cells before migration, and stated in percentage.&lt;/p></description></item><item><title>Vitamin D increasingly associated with inflammation such as RA, TB, Lupus, and cancer</title><link>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</link><pubDate>Mon, 25 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-increasingly-associated-with-inflammation-such-as-ra-tb-lupus-and-cancer.html</guid><description>&lt;h3 id="there-are-two-articles-on-this-page">There are two articles on this page&lt;/h3>
&lt;hr>
&lt;h3 id="an-update-vitamin-d-deficiency-and-risk-for-rheumatic-diseases">An Update: Vitamin D Deficiency and Risk for Rheumatic Diseases&lt;/h3>
&lt;p>Paul Gatenby, Robyn Lucas, Ashwin Swaminathan&lt;/p>
&lt;p>Curr Opin Rheumatol. 2013;25(2):184-191.&lt;/p>
&lt;h4 id="diseases-include">Diseases include&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Lupus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rheumatoid Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Juvenile Idiopathic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Systemic Vasculitis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Psoriatic Arthritis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Scleroderma&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Behcet&amp;rsquo;s Disease&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Spondyloarthropathies&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Connective Tissue Disease&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>PDF is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;hr>
&lt;h3 id="further-emergent-evidence-for-the-vitamin-d-endocrine-system-involvement-in-autoimmune-rheumatic-disease-risk-and-prognosis">Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis&lt;/h3>
&lt;p>&lt;strong>Annals of Rheumatic Diseases EDITORIAL&lt;/strong> , April 2013 Vol 72 No 4&lt;/p></description></item><item><title>Lupus and Vitamin D: good evidence, no conclusions – Review</title><link>/posts/lupus-and-vitamin-d-good-evidence-no-conclusions-review.html</link><pubDate>Wed, 30 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/lupus-and-vitamin-d-good-evidence-no-conclusions-review.html</guid><description>&lt;h2 id="the-clinical-significance-of-vitamin-d-in-systemic-lupus-erythematosus-a-systematic-review">The Clinical Significance of Vitamin D in Systemic Lupus Erythematosus: A Systematic Review&lt;/h2>
&lt;p>PLOS 1&lt;/p>
&lt;p>Rajalingham Sakthiswary &lt;a href="mailto:sakthis5@hotmail.com">sakthis5@hotmail.com&lt;/a>&lt;/p>
&lt;p>Azman Ali Raymond&lt;/p>
&lt;p>Background: Vitamin D deficiency is more prevalent among SLE patients than the general population. Over the past decade, many studies across the globe have been carried out to investigate the role of vitamin D in SLE from various clinical angles. Therefore, the aim of this systematic review is to summarise and evaluate the evidence from the published literature; focusing on the clinical significance of vitamin D in SLE.&lt;/p></description></item><item><title>Lupus flareups cut in half by just 2,000 IU of vitamin D – RCT</title><link>/posts/lupus-flareups-cut-in-half-by-just-2000-iu-of-vitamin-d-rct.html</link><pubDate>Tue, 08 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/lupus-flareups-cut-in-half-by-just-2000-iu-of-vitamin-d-rct.html</guid><description>&lt;h4 id="the-effect-of-vitamin-d-supplementation-on-inflammatory-and-hemostatic-markers-and-disease-activity-in-patients-with-systemic-lupus-erythematosus-a-randomized-placebo-controlled-trial">The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial&lt;/h4>
&lt;p>The Journal of Rheumatology jrheum.111594 Published online before print December 1, 2012,&lt;/p>
&lt;p>Anna Abou-Raya, Suzan Abou-Raya and Madihah Helmii&lt;/p>
&lt;p>From the Internal Medicine Department, Faculty of Medicine, University of Alexandria; the Biochemistry Department, Medical Research Institute; and the Alexandria Centre for Women’s Health, Alexandria, Egypt.&lt;/p>
&lt;p>A. Abou-Raya, MD, Rheumatology and Immunology Department, Faculty of Medicine, University of Alexandria, and Alexandria Centre for Women’s Health; S. Abou-Raya, MD, Internal Medicine Department, Faculty of Medicine, University of Alexandria, and Alexandria Centre for Women’s Health; M. Helmii, MD, Biochemistry Department, Medical Research Institute.&lt;/p></description></item><item><title>When lupus affects the kidneys vitamin D levels drop even further</title><link>/posts/when-lupus-affects-the-kidneys-vitamin-d-levels-drop-even-further.html</link><pubDate>Wed, 28 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/when-lupus-affects-the-kidneys-vitamin-d-levels-drop-even-further.html</guid><description>&lt;h1 id="the-predictive-factors-of-low-serum-25-hydroxyvitamin-d-and-vitamin-d-deficiency-in-patients-with-systemic-lupus-erythematosus">The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus.&lt;/h1>
&lt;p>Rheumatol Int. 2012 Nov 22.&lt;/p>
&lt;p>Sumethkul K, Boonyaratavej S, Kitumnuaypong T, Angthararuk S, Cheewasat P, Manadee N, Sumethkul V.&lt;/p>
&lt;p>Rheumatology Unit, Department of Medicine, Rajavithi Hospital, 2 Rajavithi Road, Bangkok, 10400, Thailand, &lt;a href="mailto:ckittiwan@hotmail.com">ckittiwan@hotmail.com&lt;/a>.&lt;/p>
&lt;p>Vitamin D is a steroid hormone with pleiotropic effects. The association between serum 25-hydroxyvitamin D level &lt;span>[25(OH) D]&lt;/span> and lupus nephritis are not clearly known. We aim to determine serum 25(OH) D levels in patients with inactive SLE, active SLE without lupus nephritis (LN) and active SLE with LN and to identify clinical predictor of vitamin D deficiency. One hundred and eight SLE patients were included. Patients were classified as Group (Gr) 1, 2 and 3 if they had SLE disease activity index (SLEDAI) &amp;lt;3, ≥3 but no LN and ≥3 with LN. Important baseline characteristics were collected. 25(OH) D was measured by high performance liquid chromatography (HPLC). SLEDAI in Gr1, Gr2 and Gr3 was 0.7 (0.9), 5.6 (2.3) and 9.2 (5.2), respectively. 43.5 % had vitamin D insufficiency and 29.6 % had vitamin D deficiency. Mean 25(OH) D in each groups was 28.3 (8.0), 26.7 (9.5) and 19.9 (7.6) ng/ml (p &amp;lt; 0.001 comparing Gr1 and 3) (p = 0.003 comparing Gr2 and 3). Vitamin D deficiency was found in 11.1, 22.2 and 55.6 % of Gr1, 2 and 3. Linear regression analysis found that 25(OH) D was significantly correlated with serum albumin (r = 0.28, p = 0.004), inversely correlated with SLEDAI (r = -0.22, p = 0.03) and urinary protein creatinine index (UPCI) (r = -0.28, p = 0.005), but not with sun exposure score, body mass index and estimated GFR. Only UPCI was significantly inversely correlated with 25(OH) D (p = 0.02) from multiple linear regression. LN was a significant predictor of vitamin D deficiency from multivariate logistic regression (OR &lt;strong>5.97&lt;/strong> ; p = 0.006). Vitamin D deficiency and insufficiency was found in 93 and 86 % of LN with proteinuria ≥ and &amp;lt;500 mg/day. We conclude that SLE patients with LN have significantly lower vitamin D level than inactive SLE and active SLE without LN. Hence, nephritis is a significant predictor of vitamin D deficiency in SLE patients.&lt;/p></description></item><item><title>Hypothesis of Autoimmunity which includes Epstein-Barr Virus and Vitamin D Deficiency – 2012</title><link>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</guid><description>&lt;h4 id="cd8-t-cell-deficiency-epstein-barr-virus-infection-vitamin-d-deficiency-and-steps-to-autoimmunity-a-unifying-hypothesis">CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis&lt;/h4>
&lt;p>Autoimmune Diseases, Volume 2012 (2012), Article ID 189096, 16 pages, Review Article&lt;/p>
&lt;p>Michael P. Pender 1,2&lt;/p>
&lt;p>1 School of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia&lt;/p>
&lt;p>2 Department of Neurology, Royal Brisbane and Women&amp;rsquo;s Hospital, Brisbane, QLD 4029, Australia&lt;/p>
&lt;p>Received 18 August 2011; Revised 3 October 2011; Accepted 16 October 2011&lt;/p>
&lt;p>Academic Editor: Corrado Betterle&lt;/p></description></item><item><title>Lupus flares totally eliminated by loading dose then 100000 IU of vitamin D each month</title><link>/posts/lupus-flares-totally-eliminated-by-loading-dose-then-100000-iu-of-vitamin-d-each-month.html</link><pubDate>Wed, 17 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/lupus-flares-totally-eliminated-by-loading-dose-then-100000-iu-of-vitamin-d-each-month.html</guid><description>&lt;h4 id="restoration-of-regulatory-and-effector-t-cell-balance-and-b-cell-homeostasis-in-systemic-lupus-erythematosus-patients-through-vitamin-d-supplementation">Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation&lt;/h4>
&lt;p>Benjamin Terrier, Nicolas Derian, Yoland Schoindre, Wahiba Chaara, Guillaume Geri, Noel Zahr, Kuberaka Mariampillai, Michelle Rosenzwajg, Wassila Carpentier, Lucile Musset, Jean-Charles Piette, Adrien Six, David Klatzmann, David Saadoun, Patrice Cacoub and Nathalie Costedoat-Chalumeau&lt;/p>
&lt;p>Arthritis Research &amp;amp; Therapy 2012, 14:R221 doi:10.1186/ar4060&lt;/p>
&lt;p>Published: 17 October 2012&lt;/p>
&lt;p>Introduction: Systemic lupus erythematosus (SLE) is a T and B cell-dependent autoimmune disease characterized by the appearance of autoantibodies, a global regulatory T cells (Tregs) depletion and an increase in Th17 cells. Recent studies have shown the multifaceted immunomodulatory effects of vitamin D, notably the expansion of Tregs and the decrease of Th1 and Th17 cells. A significant correlation between higher disease activity and lower serum 25-hydroxyvitamin D levels &lt;span>[25(OH)D]&lt;/span> was also shown.&lt;/p></description></item><item><title>Lupus increased when whites had low vitamin D (winter)</title><link>/posts/lupus-increased-when-whites-had-low-vitamin-d-winter.html</link><pubDate>Thu, 22 Mar 2012 00:00:00 +0000</pubDate><guid>/posts/lupus-increased-when-whites-had-low-vitamin-d-winter.html</guid><description/></item><item><title>Vitamin D deficiency and diabetes – rheumatoid arthritis – lupus</title><link>/posts/vitamin-d-deficiency-and-diabetes-rheumatoid-arthritis-lupus.html</link><pubDate>Sat, 06 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-and-diabetes-rheumatoid-arthritis-lupus.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="disease-specific-definitions-of-vitamin-d-deficiency-need-to-be-established-in-autoimmune-and-non-autoimmune-chronic-diseases-a-retrospective-comparison-of-three-chronic-diseases">Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases&lt;/h1>
&lt;p>Arthritis Res Ther. 2010; 12(5): R191. 10.1186/ar3161&lt;/p>
&lt;p>Anna R Broder, corresponding author1 Jonathan N Tobin,2,3 and Chaim Putterman1&lt;/p>
&lt;p>1Division of Rheumatology, Albert Einstein College of Medicine/Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY 10461, USA&lt;/p>
&lt;p>2Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA&lt;/p></description></item><item><title>Vitamin D patent for treating immune system diseases</title><link>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</link><pubDate>Sun, 03 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</guid><description>&lt;h2 id="wo2008039409httpwwwwipointpatentscopesearchenwo2008039409-world-wide-patent---2008">&lt;a href="http://www.wipo.int/patentscope/search/en/WO2008039409">(WO2008039409)&lt;/a> World-Wide patent - 2008&lt;/h2>
&lt;h4 id="treatment-and-prevention-of-diseases-or-conditions-of-the--immune-system-or-infectious-diseases">TREATMENT AND PREVENTION OF DISEASES OR CONDITIONS OF THE &lt;strong>IMMUNE SYSTEM OR INFECTIOUS DISEASES&lt;/strong>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>allergic rhinitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>eczema,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>psoriasis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>food allergy,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>type-1 diabetes,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>ulcerative colitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Crohn&amp;rsquo;s disease,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>rheumatoid arthritis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>multiple sclerosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>lupus,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>tuberculosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>parasitic infection, etc,&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Lupus 8X more likely to not even have 20 ng of vitamin D</title><link>/posts/lupus-8x-more-likely-to-not-even-have-20-ng-of-vitamin-d.html</link><pubDate>Thu, 19 May 2011 00:00:00 +0000</pubDate><guid>/posts/lupus-8x-more-likely-to-not-even-have-20-ng-of-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-deficiency-is-associated-with-an-increased-autoimmune-response-in-healthy-individuals-and-in-patients-with-systemic-lupus-erythematosus">Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus.&lt;/h3>
&lt;p>Ann Rheum Dis. 2011 May 17.&lt;/p>
&lt;p>Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, Dedeke AB, Harley JB, Scofield RH, Guthridge JM, James JA.&lt;/p>
&lt;p>1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.&lt;/p>
&lt;p>OBJECTIVES:&lt;/p>
&lt;p>Vitamin D deficiency is widespread and has been associated with many chronic diseases, including autoimmune disorders. A study was undertaken to explore the impact of low vitamin D levels on autoantibody production in healthy individuals, as well as B cell hyperactivity and interferon ? (IFN?) activity in patients with systemic lupus erythematosus (SLE).&lt;/p></description></item><item><title>Lupus in vicious circle with vitamin D</title><link>/posts/lupus-in-vicious-circle-with-vitamin-d.html</link><pubDate>Tue, 02 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/lupus-in-vicious-circle-with-vitamin-d.html</guid><description>&lt;h1 id="vitamin-d-in-lupus---new-kid-on-the-block">Vitamin D in lupus - new kid on the block?&lt;/h1>
&lt;p>Bull NYU Hosp Jt Dis. 2010;68(3):218-22.&lt;/p>
&lt;p>Kamen DL, Medical University of South Carolina College of Medicine, Charleston, South Carolina 29425, USA. &lt;a href="mailto:kamend@musc.edu">kamend@musc.edu&lt;/a>&lt;/p>
&lt;p>Vitamin D is an essential steroid hormone, with well established effects on mineral metabolism, skeletal health, and recently established effects on the cardiovascular and immune systems. Vitamin D deficiency is highly prevalent and evidence is mounting that it contributes to the morbidity and mortality of multiple chronic diseases, including systemic lupus erythematosus (SLE). Patients with SLE avoid the sun because of photosensitive rashes and potential for disease fare, so adequate oral supplementation is critical. This review will describe the prevalence of vitamin D deficiency in patients with SLE, identify risk factors for deficiency, describe the consequences of deficiency, and review current vitamin D recommendations for patients with rheumatic diseases. PMID: 20969555&lt;/p></description></item><item><title>Vitamin D deficiency prevalent with Lupus R-Arthritis and Diabetes</title><link>/posts/vitamin-d-deficiency-prevalent-with-lupus-r-arthritis-and-diabetes.html</link><pubDate>Sat, 16 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-prevalent-with-lupus-r-arthritis-and-diabetes.html</guid><description>&lt;h1 id="disease-specific-definitions-of-vitamin-d-deficiency-need-to-be-established-in-autoimmune-and-non-autoimmune-chronic-diseases-a-retrospective-comparison-of-three-chronic-diseases">Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases.&lt;/h1>
&lt;p>Arthritis Res Ther. 2010 Oct 14;12(5):R191.&lt;/p>
&lt;p>Broder AR, Tobin JN, Putterman C.&lt;/p>
&lt;p>INTRODUCTION: We compared the odds of vitamin D deficiency in three chronic diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 2 diabetes (T2DM), adjusting for medications, demographics, and laboratory parameters, common to all three diseases. We also designed multivariate models to determine whether different factors are associated with vitamin D deficiency in different racial/ethnic groups.&lt;/p></description></item><item><title>Taking vitamin D reduced Lupus fatigue</title><link>/posts/taking-vitamin-d-reduced-lupus-fatigue.html</link><pubDate>Fri, 03 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/taking-vitamin-d-reduced-lupus-fatigue.html</guid><description>&lt;h1 id="changes-in-vitamin-d-levels-in-patients-with-systemic-lupus-erythematosus-effects-on-fatigue-disease-activity-and-damage">Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage.&lt;/h1>
&lt;p>Arthritis Care Res (Hoboken). 2010 Aug;62(8):1160-5.&lt;/p>
&lt;p>Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C.&lt;/p>
&lt;p>Hospital De Cruces, Barakaldo, Spain. &lt;a href="mailto:r.irastorza@euskalnet.net">r.irastorza@euskalnet.net&lt;/a>&lt;/p>
&lt;p>OBJECTIVE: To analyze whether changes in serum 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) levels affect activity, irreversible organ damage, and fatigue in systemic lupus erythematosus (SLE).&lt;/p>
&lt;p>METHODS: We performed an observational study of 80 patients with SLE included in a previous cross-sectional study of 25(OH)D, reassessed 2 years later. Oral vitamin D(3) was recommended in those with low baseline 25(OH)D levels. The relationship between changes in 25(OH)D levels from baseline and &lt;strong>changes in fatigue (measured by a 0-10 visual analog scale&lt;/strong> &lt;span>[VAS]&lt;/span>), SLE activity (measured by the Systemic Lupus Erythematosus Disease Activity Index &lt;span>[SLEDAI]&lt;/span>), and irreversible organ damage (measured by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index &lt;span>[SDI]&lt;/span>) were analyzed.&lt;/p></description></item><item><title>Disease Database - nice links for Lupus</title><link>/posts/disease-database-nice-links-for-lupus.html</link><pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/disease-database-nice-links-for-lupus.html</guid><description>&lt;p>Links for &lt;a href="http://www.diseasesdatabase.com/ddb12782.htm">Systemic lupus erythematosus&lt;/a>.&lt;br />&lt;/p>
&lt;p>&amp;#160;&lt;/p>
&lt;table border="1">
&lt;tbody>
&lt;tr>
&lt;th>Site&lt;/th>
&lt;th>Link and description&lt;/th>
&lt;th>Content&lt;/th>
&lt;th>About&lt;/th>
&lt;/tr>
&lt;tr>
&lt;td>ADAM&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nlm.nih.gov/medlineplus/ency/article/000435.htm">Systemic lupus erythematosus: MedlinePlus Medical Encyclopedia&lt;/a>&lt;/td>
&lt;td>Patient information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=27352">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Online Mendelian Inheritance In Man&lt;/td>
&lt;td>&lt;a class="external" href="http://www.ncbi.nlm.nih.gov/omim/152700">SYSTEMIC LUPUS ERYTHEMATOSUS; SLE - OMIM Result&lt;/a>&lt;/td>
&lt;td>Subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=2886">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>American College of Rheumatology&lt;/td>
&lt;td>&lt;a class="external" href="http://www.rheumatology.org/practice/clinical/classification/SLE/sle.asp">The 1982 revised criteria for classification of systemic lupus erythematosus&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=12991">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>American College of Rheumatology&lt;/td>
&lt;td>&lt;a class="external" href="http://www.rheumatology.org/practice/clinical/classification/SLE/1997UpdateOf1982RevisedCriteriaClassificationSLE.asp">1997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=73448">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Collaborative Hypertext of Radiology&lt;/td>
&lt;td>&lt;a class="external" href="http://chorus.rad.mcw.edu/doc/00855.html">systemic lupus erythematosus (SLE)&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=10515">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/335055-overview">Systemic Lupus Erythematosus and Pregnancy: eMedicine Rheumatology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=68862">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/155230-overview">Libman-Sacks Endocarditis: eMedicine Cardiology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=14076">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1066549-overview">Neonatal Lupus Erythematosus: eMedicine Dermatology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=35234">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/809378-overview">Systemic Lupus Erythematosus: eMedicine Emergency Medicine&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=4913">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1065529-overview">Lupus Erythematosus, Discoid: eMedicine Dermatology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6805">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/261691-overview">Antiphospholipid Antibody Syndrome and Pregnancy: eMedicine Obstetrics and Gynecology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=16920">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/332244-overview">Systemic Lupus Erythematosus: eMedicine Rheumatology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=17355">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1146456-overview">Systemic Lupus Erythematosus: eMedicine Neurology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=19933">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1008066-overview">Systemic Lupus Erythematosus: eMedicine Pediatrics: General Medicine&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=20272">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1006582-overview">Neonatal Lupus and Cutaneous Lupus Erythematosus in Children: eMedicine Pediatrics: General Medicine&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=22341">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>GPnotebook&lt;/td>
&lt;td>&lt;a class="external" href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=1577451528">systemic lupus erythematosus (SLE) - General Practice Notebook&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=23506">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002265.html">Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=13986">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002922.html">Treatment for lupus nephritis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=38253">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002859.html">Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=48776">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002954.html">Drugs for discoid lupus erythematosus&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=15071">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Dermatology Image Atlas - Johns Hopkins University&lt;/td>
&lt;td>&lt;a class="external" href="http://dermatlas.med.jhmi.edu/derm/result.cfm?Diagnosis=727057759">DermAtlas: Online Dermatology Image Library dermatology image,lupus erythematosus, discoid,lupus erythematosus, discoid,lupus erythematosus, discoid,lupus erythematosus, discoid,lupus erythematosus, discoid,lupus erythematosus, discoid,lupus erythematosus&lt;/a>&lt;/td>
&lt;td>Images (photographic)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=25063">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;/tbody>
&lt;/table>
&lt;hr />
&lt;h3>Search elsewhere for Systemic lupus erythematosus&lt;/h3>
&lt;p>&lt;noscript>&lt;b class='look'>JavaScript must be enabled for some links on this page.&lt;/b>&lt;/noscript>&lt;/p></description></item><item><title>Is it time to routinely supplement Lupus patients with vitamin D?</title><link>/posts/is-it-time-to-routinely-supplement-lupus-patients-with-vitamin-d.html</link><pubDate>Sun, 30 May 2010 00:00:00 +0000</pubDate><guid>/posts/is-it-time-to-routinely-supplement-lupus-patients-with-vitamin-d.html</guid><description>&lt;h1 id="is-it-time-to-routinely-supplement-patients-with-sle-with-vitamin-d">Is it time to routinely supplement patients with SLE with vitamin D?&lt;/h1>
&lt;h2 id="serum-concentrations-of-25-oh-vitamin-d-in-patients-with-systemic-lupus-erythematosus-sle-are-inversely-related-to-disease-activity-is-it-time-to-routinely-supplement-patients-with-sle-with-vitamin-d">Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?&lt;/h2>
&lt;p>Ann Rheum Dis 2010;69:1155-1157 doi:10.1136/ard.2009.120329&lt;/p>
&lt;ul>
&lt;li>Published Online First 3 May 2010&lt;/li>
&lt;/ul>
&lt;p>Background Low serum vitamin D concentrations have been reported in several autoimmune disorders.&lt;/p>
&lt;p>Objective To assess whether low serum vitamin D concentrations are related to disease activity of patients with systemic lupus erythematosus (SLE).&lt;/p></description></item><item><title>Lupus again found to be related to vitamin D deficiency - should supplementation start?</title><link>/posts/lupus-again-found-to-be-related-to-vitamin-d-deficiency-should-supplementation-start.html</link><pubDate>Thu, 27 May 2010 00:00:00 +0000</pubDate><guid>/posts/lupus-again-found-to-be-related-to-vitamin-d-deficiency-should-supplementation-start.html</guid><description>&lt;h4 id="serum-concentrations-of-25-oh-vitamin-d-in-patients-with-systemic-lupus-erythematosus-sle-are-inversely-related-to-disease-activity--is-it-time-to-routinely-supplement-patients-with-sle-with-vitamin-d">Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: &lt;strong>is it time to routinely supplement patients with SLE with vitamin D?&lt;/strong>&lt;/h4>
&lt;p>Ann Rheumat Dis 69(6):1155-7 (2010)&lt;/p>
&lt;p>profile H Amital, profile Z Szekanecz, profile G Szücs, profile K Dankó, profile E Nagy, profile T Csépány, profile E Kiss, profile J Rovensky, profile A Tuchynova, profile D Kozakova, profile A Doria, profile N Corocher, profile N Agmon-Levin, profile V Barak, profile H Orbach, profile G Zandman-Goddard and profile Y Shoenfeld&lt;/p></description></item></channel></rss>